Cambridge University Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer Interventions: Drug: Pembrolizumab; Drug: Olaparib Sponsors: Cambridge University Hospitals NHS Foundation Trust; National Institute for Health Research, United Kingdom Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2021 Category: Research Source Type: clinical trials
